Scholarly Works per year
Scholarly Works per year
Fingerprint
Dive into the research topics where Josef Vagner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Alternaria alternata-induced airway epithelial signaling and inflammatory responses via protease-activated receptor-2 expression
Rivas, C. M., Schiff, H. V., Moutal, A., Khanna, R., Kiela, P. R., Dussor, G., Price, T. J., Vagner, J., DeFea, K. A. & Boitano, S., Feb 5 2022, In: Biochemical and Biophysical Research Communications. 591, p. 13-19 7 p.Research output: Contribution to journal › Article › peer-review
-
C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice
Kume, M., Ahmad, A., Shiers, S., Burton, M. D., DeFea, K. A., Vagner, J., Dussor, G., Boitano, S. & Price, T. J., 2022, (Accepted/In press) In: Journal of Pain.Research output: Contribution to journal › Article › peer-review
Open Access -
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse models
Rivas, C. M., Yee, M. C., Addison, K. J., Lovett, M., Pal, K., Ledford, J. G., Dussor, G., Price, T. J., Vagner, J., DeFea, K. A. & Boitano, S., May 2022, In: British Journal of Pharmacology. 179, 10, p. 2208-2222 15 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
β-arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammation
Schiff, H. V., Rivas, C. M., Pederson, W. P., Sandoval, E., Gillman, S., Prisco, J., Kume, M., Dussor, G., Vagner, J., Ledford, J. G., Price, T. J., DeFea, K. A. & Boitano, S., 2022, (Accepted/In press) In: British Journal of Pharmacology.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist
Mwirigi, J., Kume, M., Hassler, S. N., Ahmad, A., Ray, P. R., Jiang, C., Chamessian, A., Mseeh, N., Ludwig, B. P., Rivera, B. D., Nieman, M. T., Van de Ven, T., Ji, R. R., Dussor, G., Boitano, S., Vagner, J. & Price, T. J., Jun 2021, In: Journal of Pain. 22, 6, p. 692-706 15 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations
-
Protease Activated Receptor Type 2 Targeting for Migraine Pain
Project: Research project
-
Development of SP-A Derived Peptidomimetics for the Treatment of Asthma - Phase II
Ledford, J., Vagner, J., Kraft, M. & Boitano, S. A.
Project: Research project
-
Protease Activated Receptor Type 2 Targeting for Migraine Pain
Project: Research project
-
PAR2 targeted drug discovery for the treatment of pain
Project: Research project
-
Protease Activated Receptor Type 2 Targeting for Migraine Pain
7/1/16 → 6/30/17
Project: Research project
Datasets
-
Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice
Hassler, S. N. (Creator), Ahmad, F. B. (Creator), Burgos-Vega, C. C. (Creator), Boitano, S. A. (Creator), Vagner, J. (Creator), Price, T. J. (Creator) & Dussor, G. (Creator), figshare, 2018
DOI: 10.25384/sage.c.4119893.v1, https://figshare.com/collections/Protease_activated_receptor_2_PAR2_activation_causes_migraine-like_pain_behaviors_in_mice/4119893/1
Dataset